TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/18/24 16:35 | 4/16/24 | ULS | Ul Solutions Inc. | DE | Health | Biolab | Testing Laboratories | 22 | 22 | P.d | 16,539 | 28.00 | 0 | 591 | 591 | D | |||||||||||||||
3/25/24 07:07 | 3/22/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 6 | P.d | 4,846 | 4.33 | 0 | 1,120 | 63 | 2,909 | D | ||||||||||||||
3/5/24 21:30 | 3/1/24 | ABSI | Absci Corp | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P | 1,000 | 4.50 | 0 | 222 | 3 | 8,253 | I | |||||||||||||||
1/25/24 16:19 | 6/7/19 | NOTV | Inotiv, Inc. | IN | Health | Biolab | Commercial Physical & Biologi | 4 | 5 | P.d | 239 | 3.38 | 0 | 71 | 8 | 967 | I | ||||||||||||||
12/26/23 09:00 | 12/21/23 | MLCT | Malachite Innovations, Inc. | NV | Health | Biolab | Commercial Physical & Biologi | 4 | 8 | P.dm | 1,327 | 0.1226 | 0 | 10,823 | 22 | 59,731 | D | ||||||||||||||
11/21/23 17:07 | 11/20/23 | CRL | Charles River Laboratories International, Inc. | Health | Biolab | Commercial Physical & Biologi | 3 | 4 | P | 1,834 | 189.23 | 0 | 10 | 3 | 319 | D | |||||||||||||||
9/15/23 16:23 | 9/14/23 | ISPC | Ispecimen Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 2 | 2 | P | 18 | 0.8241 | 0 | 22 | 20 | 134 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |